No decision has been taken during the NTAGI meeting on Friday regarding the vaccination of children between the age group of 5-12 years against COVID19.
The meeting remained inconclusive about firming up SoP and detailed guidelines for vaccination. India's drug regulator, DCGI, had on Tuesday granted emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for those aged five to 12 years and Bharat Biotech's Covaxin for children in the age group of six to 12 years.
And following this, Union Health Minister Mansukh Mandaviya said on Thursday, "The decision (on vaccination for 5-12 age group) will be taken on the basis of the recommendation of an expert committee." National Technical Advisory Group on Immunisation (NTAGI) was scheduled to meet today regarding the same.
However, during the meeting, NTAGI approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, sources also revealed.
Read more on livemint.com